Dual-mechanism estrogen receptor inhibitors | PNAS
Estrogen Receptors: How Do They Signal and What Are Their Targets | Physiological Reviews
Non-classical genomic estrogen receptor (ER)/specificity protein and ER/activating protein-1 signaling pathways in: Journal of Molecular Endocrinology Volume 41 Issue 5 (2008)
Crossroads of Estrogen Receptor and NF-κB Signaling | Science's STKE
Transrepression of estrogen receptor and NFκB. (a) NFκB can inhibit... | Download Scientific Diagram
Fulvestrant-Induced Cell Death and Proteasomal Degradation of Estrogen Receptor α Protein in MCF-7 Cells Require the CSK c-Src Tyrosine Kinase | PLOS ONE
Selective Estrogen Receptor Degraders (SERDs): A Promising Strategy for Estrogen Receptor Positive Endocrine-Resistant Breast Cancer | Journal of Medicinal Chemistry
The NF-KB pathway and endocrine therapy resistance in breast cancer in: Endocrine-Related Cancer Volume 26 Issue 6 (2019)
Potentiation of ICI182,780 (Fulvestrant)-induced Estrogen Receptor-α Degradation by the Estrogen Receptor-related Receptor-α Inverse Agonist XCT790* - Journal of Biological Chemistry
Cross-talk between nuclear receptors and nuclear factor κB | Oncogene
The role of estrogen receptor beta in breast cancer | Biomarker Research | Full Text
Crossroads of Estrogen Receptor and NF-κB Signaling | Science's STKE
Frontiers | Estrogen Signaling in ERα-Negative Breast Cancer: ERβ and GPER
Estrogen Receptor Pathway | Progestogen Rectieptor Signaling
Molecular mechanism of estrogen–estrogen receptor signaling - Yaşar - 2017 - Reproductive Medicine and Biology - Wiley Online Library
Estrogen signaling: An emanating therapeutic target for breast cancer treatment - ScienceDirect
IJMS | Free Full-Text | The Role of ERα36 in Development and Tumor Malignancy | HTML
A Selective Ligand for Estrogen Receptor Proteins Discriminates Rapid and Genomic Signaling
Crossroads of Estrogen Receptor and NF-κB Signaling | Science's STKE
Estrogen/ER in anti-tumor immunity regulation to tumor cell and tumor microenvironment - Abstract - Europe PMC
Signaling pathways and steroid receptors modulating estrogen receptor α function in breast cancer
The NF-KB pathway and endocrine therapy resistance in breast cancer in: Endocrine-Related Cancer Volume 26 Issue 6 (2019)
A Selective Ligand for Estrogen Receptor Proteins Discriminates Rapid and Genomic Signaling
New insights into acquired endocrine resistance of breast cancer
Dual-mechanism estrogen receptor inhibitors | PNAS
Impact of Apparent Antagonism of Estrogen Receptor β by Fulvestrant on Anticancer Activity of 2-Methoxyestradiol | Anticancer Research
